Cellular cardiomyoplasty and cardiac regeneration

Current Cardiology Reviews

Volumn 4, Issue 2, 2008, Pages 72-80

  Pendyala, Lakshmana ^a   Goodchild, Traci ^a   Gadesam, Radhika R ^a   Chen, Jack ^a   Robinson, Keith ^a   Chronos, Nicolas ^a   Gou, Dongming ^a  

^a Saint Joseph's Hospital of Atlanta   (United States)

Author keywords

Bone marrow progenitor cells; Clinical trials; Heart failure; Myoblasts; Myocardial infarction; Review

Indexed keywords

ANTIARRHYTHMIC AGENT;

AMNION CELL; ARTIFICIAL HEART PACEMAKER; CARDIOMYOPATHY; CARDIOMYOPLASTY; CELL TRANSPLANTATION; CELL TYPE; CELLULAR CARDIOMYOPLASTY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CORD BLOOD STEM CELL TRANSPLANTATION; CORONARY ARTERY BYPASS GRAFT; DEFIBRILLATOR; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; ENGRAFTMENT; EVIDENCE BASED MEDICINE; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; ISCHEMIC HEART DISEASE; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPOTENT STEM CELL; MYOBLAST; NONHUMAN; PATIENT SAFETY; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REPAIR; TOTIPOTENT STEM CELL;

EID: 48249139905     PISSN: 1573403X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340308784245748     Document Type: Review

References (88)

1. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult - Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by Heart Rhythm Society. Circulation 2005; 112: 1825-52.
2. Mackay J, Mensah GA. In: The Atlas of Heart Disease and Stroke, 1st edn. Geneva: World Health Organization 2004; 1-112.
3. McAlister FA, Ezekowitz JA, Wiebe N, et al. Systematic review: cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med 2004; 141: 381-90.
4. Yancy CW. Comprehensive treatment of heart failure: state-of-the-art medical therapy. Rev Cardiovase Med 2005; 6: 43-57.
5. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Eng J Med 2002; 347: 1397-402.
6. Taylor DO, Edwards LB, Boueek MM, et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-third official adult heart transplantation report-2006. J Heart Lung Transplant 2006; 25: 869-71.
7. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure for the randomized evaluation of mechanical assistance for the treatment of congestive heart failure (REMATCH) study group. N Engl J Med 2001; 345: 1435-43.
8. Park SJ, Tector A, Piccioni W, et al. Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg 2005; 129: 9-17.
9. Pfeffer MA, McMurray JJ, Velazquez EJ, et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 2003; 349: 1893-906.
10. Lee MS, Makkar RR. Stem-cell transplantation in myocardial infarction: a status report. Ann Intern Med 2004; 140: 729-37.
11. Murry CE, Field LJ, Menasche P. Cell-based cardiac repair: reflections at the 10-year point. Circulation 2005; 112: 3174-83.
12. Verfaillie CM. Adult stem cells: assessing the case for pluripotency. Trends Cell Biol 2002; 12: 502-8.
13. Orkin SH, Zon LI. Hematopoiesis and stem cells: plasticity versus developmental heterogeneity. Nat Immunol 2002; 3: 323-8.
14. Anderson DJ, Gage FH, Weissman IL. Can stem cells cross lineage boundaries? Nat Med 2001; 7: 393-5.
15. Mathur A, Martin JF. Stem cells and repair of the heart. Lancet 2004; 364: 183-92.
16. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 2005; 115: 572-93.
17. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004; 95: 9-20.
18. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-9.
19. Pompilio G, Cannata A, Peccatori F, et al. Autologous peripheral blood stem cell transplantation for myocardial regeneration: a novel strategy for cell collection and surgical injection. Ann Thorac Surg 2004; 78: 1808-12.
20. Planat-Benard V, Menard C, Andre M, et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma. cells. Circ Res 2004; 94: 223-9.
21. Jiang Y, Vaessen B, Lenvik T, et al. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 2002; 30: 896-904.
22. Kogler G, Sensken S, Airey JA, et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004; 200: 123-35.
23. DeCoppi P, Bartsch G, Siddiqui MM, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotech 2007; 25: 100-6.
24. Oh H, Bradfute SB, Gallardo TD, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 2003; 100: 12313-8.
25. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114: 763-8.
26. Bock-Marquette I, Saxena A, White MD, et al. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 2004; 432: 466-72.
27. Kehat I, Kenyagin-Karsenti D, Snir M, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001;108: 407-14.
28. Passier R, Mummery C. Cardiomyocyte differentiation from embryonic and adult stem cells. Curr Opin Biotechnol 2005;16: 498-502.
29. Fijnvandraat AC, van Ginneken AC, Schumacher AC, et al. Cardiomyocytes purified from differentiated embryonic stem cells exhibit characteristics of early chamber myocardium. J Mol Cell Cardiol 2003; 35: 1461-72.
30. Laflamme MA, Gold J, Xu C, Hassampour M, et al. Formation of human myocardiurn in the rat heart from human embryonic stem cells. Am J Pathol 2005; 167: 663-71.
31. Kofidis T, Lebl DR, Swijnenburg RJ, et al. Allopurinol/uricase and ibuprofen enhance engraftment of cardiomyocyte-enriched human embryonic stem cells and improve cardiac function following myocardial injury. Eur J Cardiothorac Surg 2006; 29: 50-5.
32. Kajstura J, Leri A, Finato N, et al. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA 1998; 95: 8801-05.
33. Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001; 344: 1750-57.
34. Smith RR, Barile L, Cho HC, Leppo LK, et al. Regenerative capacity of Cardiosphere-derived cells expanded from percutancous endomyocardial biopsy specimens. Circulation 2007; 115: 896-908.
35. Urbanek K, Quaini F, Tasca G, et al. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci USA 2003; 100: 10440-45.
36. Nygren JM, Jovinge S, Breitbach M, et al. Bone marrowderived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004; 10: 494-501.
37. Ying QL, Nichols J, Evans EP, et al. Changing potency by spontaneous fusion. Nature 2002; 416: 545-8.
38. Aicher A, Brenner W, Zuhayra M, et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 2003; 107: 2134-9.
39. Vulliet PR, Greeley M, Halloran SM, et al. Intracoronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 2004; 363: 783-4.
40. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularisation of ischemic myocardium by human bone marrow derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001;7: 430-6.
41. Kocher AA, Schuster MD, Bonaros N, et al. Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/ Gro CXC chemokines. J Moll Cell Cardiol 2006; 40: 455-64.
42. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-5.
43. Yang S, Fazel S, Angoulvant D, et al. Cell transplantation for heart disease: the clinical perspective. Evid Based Cardiovasc Med 2005; 9: 2-7.
44. Menasche P, Hagege AA, Scorsin M, et al. Myoblast transplantation for heart failure. Lancet 2001; 357: 279-80.
45. Chin RC, Zibaitis A, Kao RL. Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg 1995; 60: 12-8.
46. Bonaros N, Rauf R, Wolf D, et al. Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic ischemic heart failure. J Thorac Cardiovasc Surg 2006; 132: 1321-8.
47. Taylor DA, Atkins BZ, Hungspreugs P, et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998; 4: 929-33.
48. Abraham MR, Henrikson CA, Tung L, et al. Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circ Res 2005; 97: 159-67.
49. Reinecke H, Poppa V, Murry CE. Skeletal muscle stem cells do no transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 2002; 34: 241-9.
50. Smits PC, van Geuns RJ, Poldermans D, et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month followup. J Am Coll Cardiol 2003; 42: 2063-9.
51. Menasche P, Hagege AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003; 41(7):1078-83.
52. Dib N, Michler RE, Pagani FD, et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 2005; 112: 1748-55.
53. Herreros J, Prosper F, Perez A, et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 2003, 24: 2012-20.
54. Ince H, Petzsch M, Rchders TC, et al.: Transcatheter transplantation of autologous skeletal myoblasts in postinfarction patients with severe left ventricular dysfunction. J Endovasc Ther 2004, 11: 695-704.
55. Siminiak T, Fiszer D, Jerzykowska O, et al.: Percutaneous transcoronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial. Eur Heart J 2005, 26: 1188-95.
56. Cleland JG, Coletta AP, Abdellah AT, et al. Clinical trials update from the American Heart Association 2006: OAT, SALT 1 and 2, MAGIC, ABCD, PABA-CHF, IMPROVECHF, and percutaneous mitral annuloplasty. Eur J Heart Fail 2007; 9: 92-7.
57. Ferrari G, Cusella-De Angelis G, Coletta M, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998; 279: 1528-30.
58. Krause DS, Theise N, Collector K et al. Multi-organ, multilineage engraftment by a single bone marrow-derived stem cell. Cell 2001; 105: 369-77.
59. Mezey E, Chandross KJ, Harta G, et al. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000; 290: 1779-82.
60. Osawa M, Nakamura K, Nishi N, et al. In vivo self-renewal of c-Kit+ Sca-1+ Lin(low/-) hemopoietic stem cells. J Immunol 1996; 156: 3207-14.
61. Spangrude GJ, Heimfeld S, Weissman IL, et al. Purification and characterization of mouse hematopoietic stem cells. Science 1988;241: 58-62.
62. Goldman JM, Horowitz MM. The international bone marrow transplant registry. Int J Hematol 2002; 76: 393-7.
63. Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001; 98: 10344-9.
64. Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001;107: 1395-02.
65. Friedenstein AJ, Petrakova KV, Kurolesova AI, et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968; 6: 230-47.
66. Tavassoli M, Crosby WH. Transplantation of marrow to extramedullary sites. Science 1968; 161: 54-6.
67. Conget PA, Minguell JJ. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 1999; 181: 67-73.
68. Pittenger MF, Mackay AK Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-47.
69. Azizi SA, Stokes D, Augelli BJ, et al. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-similarities to astrocyte grafts. Proc Natl Acad Sci USA 1998; 95: 3908-13.
70. Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999; 103: 697-705.
71. Pereira RF, Halford KW, O'Hara MD, et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci USA 1995; 92: 4857-61.
72. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-67.
73. Gehling UM, Ergun S, Schumacher U, et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000; 95: 3106-12.
74. Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34 (+) cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-58.
75. Shi Q, Rafii S, Wu MH, et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998; 92: 362-67.
76. Rosenzweig A. Cardiac cell therapy - mixed results from mixed cells. N Engl J Med 2006; 355: 1274-77.
77. Schachinger V, Erbs S, Elsasser A, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006; 355: 1210-21.
78. Meyer GP, Wollert KC, Lotz J, et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (Bone marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006; 113: 1287-94.
79. Lunde K, Solheim S, Aakhus S, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006; 355: 1199-09.
80. Janssens S, Dubois C, Bogaert J, et al. Autologous bone marrow-derived stem-cell transfer in patients with STsegment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006; 367: 113-21.
81. Assmus B, Honold J, Schachinger V, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006; 355: 1222-32.
82. Perin EC, Dohmann HF, Borejevic R, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003; 107: 2294-02.
83. Zimmermann WH, Melnychenko I, Wasmeier G, et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 2006; 12: 452-58.
84. Ott HC, Matthiesen TS, Goh SK, Black LD, et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008; 14: 213-21.
85. Lenzen MJ, Boersma E, Bertrand ME, et al. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. Eur Heart J 2005; 26: 1169-79.
86. Mangi AA, Noiseux N, Kong D, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003; 9: 1195-01. 87 Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600.
87. Minatoguchi S, Takemura G, Chen XH, et al. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor. Circulation 2004; 109: 2572-80.
88. Murry CE, Soonpaa MH, Reinecke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004; 428: 664-8.